pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,414 catalysts · 3,359 8k filing · 1,080 grant · 1,000 device adverse event · 579 earnings · 519 approval · 408 device 510k

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-17: 10 catalysts2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-03-04×clear all
type
  • 8k filing3,359
  • grant1,080
  • device adverse event1,000
  • earnings579
  • approval519
  • device 510k408
  • device pma236
  • phase 2 completion172
  • drug shortage133
  • recall121
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Mar 23, 2026

    50
    ›Mar 26, 2026approval145d agoKADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approvaltrastuzumab emtansine

    Sponsor: GENENTECH. Form: VIAL. Route: SINGLE-USE

    full page →trastuzumab emtansine →fda approvals ↗
    ›Mar 26, 2026approval145d agoAWIQLI FLEXTOUCH (INSULIN ICODEC) — FDA approvalinsulin icodec

    Sponsor: NOVO NORDISK INC. Form: INJECTION. Route: SOLUTION

    full page →insulin icodec →fda approvals ↗
    ›Mar 26, 2026approval145d agoLABETALOL HYDROCHLORIDE — FDA approvalLABETALOL HYDROCHLORIDE

    Sponsor: HERITAGE PHARMA. Form: TABLET. Route: ORAL

    full page →LABETALOL HYDROCHLORIDE →fda approvals ↗
    ›Mar 26, 2026approval145d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

    Sponsor: ALEMBIC. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →DOXYCYCLINE HYCLATE →fda approvals ↗
    ›Mar 26, 2026approval145d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

    Sponsor: ALEMBIC. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →DOXYCYCLINE HYCLATE →fda approvals ↗
    ›Mar 26, 2026approval145d agoPAROXETINE HYDROCHLORIDE — FDA approvalPAROXETINE HYDROCHLORIDE

    Sponsor: ALEMBIC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →PAROXETINE HYDROCHLORIDE →fda approvals ↗
    ›Mar 26, 2026approval145d agoNEFFY (EPINEPHRINE) — FDA approvalInternational Medication Systems Ltd

    Sponsor: ARS PHARMS OPERATION. Form: SPRAY. Route: NASAL

    full page →fda approvals ↗
    ›Mar 26, 2026approval145d agoNEFFY (EPINEPHRINE) — FDA approvalInternational Medication Systems Ltd

    Sponsor: ARS PHARMS OPERATION. Form: SPRAY. Route: NASAL

    full page →fda approvals ↗
    ›Mar 26, 2026approval145d agoTAFINLAR (DABRAFENIB MESYLATE) — FDA approvaldabrafenib mesylate ODT

    Sponsor: NOVARTIS. Form: CAPSULE. Route: ORAL

    full page →dabrafenib mesylate ODT →fda approvals ↗
    ›Mar 26, 2026device 510k145d agoLunit, Inc. — Lunit INSIGHT DBT (V1.2) (510k cleared)

    Product code: QDQ. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 26, 2026device 510k145d agoMedtronic Navigation, Inc. — Stealth AXiS Cranial clinical application (510k cleared)

    Product code: HAW. Advisory committee: Neurology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 26, 2026device 510k145d agoVizaramed, Inc. — Multiflex Steerable Sheath 17.5F (510k cleared)

    Product code: DYB. Advisory committee: Cardiovascular. Type: Special

    full page →fda device 510k ↗
    ›Mar 26, 2026device 510k145d agoSurgify Medical OY — Surgify Halo (54.085.SHD.U1); Surgify Halo (54.140.SHD. U1); Surgify Halo (54.070.NVG.U1); Surgify Halo (54.125.NVG.U1); Surgify Halo (54.000.SEE.U1); Surgify Halo (40.070.NVG.U1); Surgify Halo (40.125.NVG.U1); Surgify Halo (40.000.SEE.U1); Surgify Halo (30.070.NVG.U2); Surgify Halo (30.125.NVG.U2); Surgify Halo (30.000.SEE.U2) (510k cleared)

    Product code: HBE. Advisory committee: Neurology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 26, 2026device 510k145d agoBIOMERIEUX — VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL) (510k cleared)

    Product code: LON. Advisory committee: Microbiology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 26, 2026device 510k145d agoBlue Belt Technologies, Inc. — REAL INTELLIGENCE™ CORI™ (510k cleared)BETA Technologies, Inc.

    Product code: OLO. Advisory committee: Neurology. Type: Special

    full page →fda device 510k ↗
    ›Mar 26, 2026device 510k145d agoDevilbiss Healthcare, LLC — DeVilbiss 5 Liter Oxygen Concentrator (555) (510k cleared)

    Product code: CAW. Advisory committee: Anesthesiology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 26, 2026device 510k145d agoShenzhen Urion Technology Co., Ltd. — Automatic Electronic Blood Pressure Monitor (U90B series models including ( U90B,U90B Pro,U90B Plus,U90B Ultra,U90C,U90C Pro,U90C Plus,U90C Ultra).) (510k cleared)Fortior Technology (Shenzhen) Co., Ltd./ADR

    Product code: DXN. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 26, 2026device 510k145d agoAirs Medical, Inc. — SwiftMR (510k cleared)AVITA Medical, Inc.

    Product code: QIH. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 26, 2026device 510k145d agoRestore Robotics — Robotic Surgical Instruments - Permanent Cautery Hook (470183); Robotic Surgical Instruments - Permanent Cautery Spatula (470184) (510k cleared)

    Product code: QSM. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 26, 2026device pma145d agoMedinol, Ltd. — EluNIR™ Ridaforolimus Eluting Coronary Stent System (PMA supplement)IGC Pharma, Inc.

    Supplement type: 30-Day Notice. Product code: NIQ. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Mar 26, 2026device pma145d agoMedtronic Neuromodulation — Altaviva™ (PMA supplement)

    Supplement type: Normal 180 Day Track No User Fee. Product code: QPT. Advisory committee: GU. Decision: APPR

    full page →fda device pma ↗
    ›Mar 26, 2026device pma145d agoBolton Medical, Inc. — TREO® Abdominal Stent-Graft System (PMA supplement)

    Supplement type: Normal 180 Day Track. Product code: MIH. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Mar 26, 2026grant145d agoMEDICAL UNIVERSITY OF SOUTH CAROLINA — Data Analytics Training And Professional Development (DATA-Pro) for Behaviora...

    CA grant. $215,976. PI: Kalyani Sonawane

    full page →nih reporter ↗
    ›Mar 26, 2026grant145d agoUNIVERSITY OF CALIFORNIA, SAN DIEGO — The Impact of Bile Salt Hydrolase on Intestinal T Cells in ColitisUniversity of California San Diego

    DK grant. $43,313. PI: Elizabeth A Brown

    full page →nih reporter ↗
    ›Mar 26, 2026grant145d agoOREGON HEALTH & SCIENCE UNIVERSITY — A microphysiological model of prostate cancer metastasis into vascularized an...

    CA grant. $521,002. PI: Luiz Eduardo Bertassoni

    full page →nih reporter ↗
    ›Mar 26, 2026grant145d agoOREGON HEALTH & SCIENCE UNIVERSITY — Direct and indirect MCL1 targeting for high-efficiency therapy of lung metast...

    CA grant. $625,179. PI: Alexander E Davies

    full page →nih reporter ↗
    ›Mar 27, 2026approval144d agoEPKINLY (EPCORITAMAB-BYSP) — FDA approvalepcoritamab

    Sponsor: GENMAB US, INC.. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →epcoritamab →fda approvals ↗
    ›Mar 27, 2026approval144d agoALYFTREK (DEUTIVACAFTOR) — FDA approval(deutivacaftor + tezacaftor + vanzacaftor calcium)

    Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL

    full page →(deutivacaftor + tezacaftor + vanzacaftor calcium) →fda approvals ↗
    ›Mar 27, 2026approval144d agoALLI (ORLISTAT) — FDA approvalH2-Pharma LLC

    Sponsor: HALEON US HOLDINGS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 27, 2026approval144d agoPONLIMSI (DENOSUMAB-ADET) — FDA approvalPONLIMSI

    Sponsor: TEVA PHARMACEUTICALS, INC.. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →PONLIMSI →fda approvals ↗
    ›Mar 27, 2026approval144d agoZEJULA (NIRAPARIB TOSYLATE) — FDA approvalniraparib

    Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL

    full page →niraparib →fda approvals ↗
    ›Mar 27, 2026approval144d agoDAYBUE (TROFINETIDE) — FDA approvaltrofinetide

    Sponsor: ACADIA PHARMS INC. Form: SOLUTION. Route: ORAL

    full page →trofinetide →fda approvals ↗
    ›Mar 27, 2026approval144d agoCARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER (NICARDIPINE HYDROCHLORIDE) — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: CHIESI. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Mar 27, 2026approval144d agoDIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE (ATROPINE SULFATE) — FDA approvalATROPINE SULFATE

    Sponsor: SPECGX LLC. Form: TABLET. Route: ORAL

    full page →ATROPINE SULFATE →fda approvals ↗
    ›Mar 27, 2026approval144d agoASENAPINE MALEATE — FDA approvalASENAPINE MALEATE

    Sponsor: SIGMAPHARM LABS LLC. Form: TABLET. Route: SUBLINGUAL

    full page →ASENAPINE MALEATE →fda approvals ↗
    ›Mar 27, 2026approval144d agoTRIKAFTA (COPACKAGED) (ELEXACAFTOR, IVACAFTOR, TEZACAFTOR) — FDA approvalTRIKAFTA (COPACKAGED)

    Sponsor: VERTEX PHARMS INC. Form: TABLET. Route: ORAL

    full page →TRIKAFTA (COPACKAGED) →fda approvals ↗
    ›Mar 27, 2026approval144d agoHALOPERIDOL DECANOATE — FDA approvalHALOPERIDOL DECANOATE

    Sponsor: MANKIND PHARMA. Form: INJECTABLE. Route: INJECTION

    full page →HALOPERIDOL DECANOATE →fda approvals ↗
    ›Mar 27, 2026approval144d agoSPINRAZA (NUSINERSEN SODIUM) — FDA approvalBIOGEN INC.

    Sponsor: BIOGEN IDEC. Form: SOLUTION. Route: INTRATHECAL

    full page →fda approvals ↗
    ›Mar 27, 2026approval144d agoLICART (DICLOFENAC EPOLAMINE) — FDA approvalAmzell Limited

    Sponsor: IBSA INST BIO. Form: SYSTEM. Route: TOPICAL

    full page →fda approvals ↗
    ›Mar 27, 2026approval144d agoTRIKAFTA (COPACKAGED) (ELEXACAFTOR, IVACAFTOR, TEZACAFTOR) — FDA approvalTRIKAFTA (COPACKAGED)

    Sponsor: VERTEX PHARMS INC. Form: GRANULES. Route: ORAL

    full page →TRIKAFTA (COPACKAGED) →fda approvals ↗
    ›Mar 27, 2026approval144d agoESCITALOPRAM OXALATE — FDA approvalAbbVie Inc.

    Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 27, 2026approval144d agoESCITALOPRAM OXALATE — FDA approvalAbbVie Inc.

    Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 27, 2026approval144d agoESCITALOPRAM OXALATE — FDA approvalAbbVie Inc.

    Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 27, 2026approval144d agoESCITALOPRAM OXALATE — FDA approvalAbbVie Inc.

    Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 27, 2026approval144d agoESCITALOPRAM OXALATE — FDA approvalAbbVie Inc.

    Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 27, 2026approval144d agoESCITALOPRAM OXALATE — FDA approvalAbbVie Inc.

    Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 27, 2026approval144d agoESCITALOPRAM OXALATE — FDA approvalAbbVie Inc.

    Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 27, 2026approval144d agoESCITALOPRAM OXALATE — FDA approvalAbbVie Inc.

    Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 27, 2026approval144d agoESCITALOPRAM OXALATE — FDA approvalAbbVie Inc.

    Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 27, 2026approval144d agoKETAMINE HYDROCHLORIDE — FDA approvalKetalar

    Sponsor: GLAND. Form: INJECTABLE. Route: INJECTION

    full page →Ketalar →fda approvals ↗
    ← prev
    page 21 of 149
    next →
    $ACAD28.24-0.49%
    $AMRX18.15+5.10%
    $VERX12.72-4.00%
    $NVS150.88-0.55%
    $FRTRY
    $NVO45.89-1.78%
    $IGC0.2670+0.41%
    $TERN52.95-0.03%
    $RCEL7.8500-2.00%
    $BETA16.10+2.09%
    $BIIB209.83-0.39%
    $VERX12.72-4.00%
    $VERX12.72-4.00%
    $ABBV249.46-0.54%
    $ABBV249.46-0.54%
    $ABBV249.46-0.54%
    $ABBV249.46-0.54%
    $ABBV249.46-0.54%
    $ABBV249.46-0.54%
    $ABBV249.46-0.54%
    $ABBV249.46-0.54%
    $ABBV249.46-0.54%